HALOVSSBFM• 28 Days (Normalized)
HALO vs SBFM (Halozyme Therapeutics Inc. vs Sunshine Biopharma Inc.)
Showing Closing Date Range from Sep 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HALO Performance $109.72
+2.17%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
SBFM Performance $0.4
-64.47%
Sunshine Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
+66.64 pts
HALO outperforming by 66.64 percentage points
HALOSBFM
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HALO SBFM
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | HALO Price | HALO Gain (%) | SBFM Price | SBFM Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $109.72 | +2.17% | $0.40 | -64.47% | +66.64% |
| Oct 05, 2026 | $108.31 | +0.86% | $0.42 | -62.49% | +63.35% |
| Oct 02, 2026 | $109.86 | +2.30% | $0.67 | -40.49% | +42.79% |
| Oct 01, 2026 | $106.94 | -0.42% | $- | - | |
| Sep 30, 2026 | $110.40 | +2.80% | $0.77 | -30.98% | +33.78% |
| Sep 29, 2026 | $111.56 | +3.88% | $0.79 | -29.73% | +33.61% |
| Sep 28, 2026 | $112.89 | +5.12% | $0.82 | -26.96% | +32.08% |
| Sep 25, 2026 | $113.90 | +6.06% | $0.84 | -24.73% | +30.79% |
| Sep 24, 2026 | $- | $0.80 | -28.57% | - | |
| Sep 23, 2026 | $112.44 | +4.70% | $0.88 | -21.79% | +26.49% |
| Sep 22, 2026 | $115.13 | +7.21% | $0.91 | -19.11% | +26.32% |
| Sep 21, 2026 | $111.45 | +3.78% | $0.91 | -18.84% | +22.62% |
| Sep 18, 2026 | $112.45 | +4.71% | $0.90 | -19.64% | +24.35% |
| Sep 17, 2026 | $109.68 | +2.13% | $0.84 | -24.91% | +27.04% |
| Sep 16, 2026 | $108.44 | +0.98% | $1.03 | -8.04% | +9.02% |
Page 1 of 2